JDV Pharma SRL
JDV Pharma reported total assets of €1.56m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Apr 2026).
The score of JDV Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -4 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JDV Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Apr 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 03 Apr 2024
- Year ended 31 Dec 2022filed on 18 Apr 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
JDV Pharma's financial analysis
- Solvency43.4%sector median: 38.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JDV Pharma
JDV Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0538.789.765
- VAT number
- BE0538789765
- Peppol
- Registered · 0208:0538789765 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2013
- Registered office
- 2811 Mechelen
- Latest accounts
- 2025 · filed on 27 Apr 2026
- Activity
- Activities of managing agents of real estate (NACE 68321)
JDV Pharma (SRL) has been based in Mechelen since 2013, active in: activities of managing agents of real estate. For 2025, it reports a net profit of 80,318 € and equity of 675,423 €; its revenue is not published. Its solvency stands at 43.4%, above the median of its sector (38.8%).
Companies similar to JDV Pharma
Companies in the same business, of comparable size and area, outside its group.
- Vansteenlandt & C° Other real estate activities on a fee or contract basis Kontich · balance sheet €1.63m
- Panorama B2B Activities of holding companies Bruges · balance sheet €2.01m
- Muylaert & Zonen Other real estate activities on a fee or contract basis Saint-Gilles · balance sheet €1.62m
- Bawa - Invest Other real estate activities on a fee or contract basis Zele · balance sheet €1.73m
- Duin Construct Other real estate activities on a fee or contract basis Haacht · balance sheet €1.85m
- Jennick Other real estate activities on a fee or contract basis Haaltert · balance sheet €1.93m
- RKP Invest Other real estate activities on a fee or contract basis Waregem · balance sheet €1.99m
- Pascal Bollen Assurances Other real estate activities on a fee or contract basis Neupré · balance sheet €1.99m
Frequently asked questions about JDV Pharma
What is the revenue of JDV Pharma?
JDV Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JDV Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0538789765 for JDV Pharma, if the company is VAT-registered. Its company number (CBE) is 0538.789.765.
Where is the registered office of JDV Pharma?
According to the CBE register, the registered office of JDV Pharma is in 2811 Mechelen.
What is the equity of JDV Pharma?
At the close of the 2025 financial year, the equity of JDV Pharma amounts to 675,423 €, a solvency of 43.4% of total assets.
Who manages JDV Pharma?
The register lists 1 active mandates at JDV Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JDV Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →